Gabriel India Ltd. 4 th November, 2014 BUY

Similar documents
Va Tech Wabag Ltd. 11 th March, 2014 BUY

R.S. Software (India) Ltd. 11 th August, 2014 BUY

Munjal Showa Ltd 30 th May, 2012

Idea Cellular Ltd. 19 th January, 2015 BUY

NIIT Technologies Ltd. 15 th February, 2016 BUY

Ceat Ltd 1 st June, 2013 BUY

Minda Corporation Ltd. 29 th December, 2015 BUY

Steel Strips Wheels Ltd. 6 th August, 2016 BUY

Tech Mahindra Ltd 21 st September, 2013 BUY

Camlin Fine Sciences Ltd. 27 th June, 2015 BUY

Pidilite Industries Ltd 10 th September, 2012

V-Guard Industries Ltd 9 th June, 2012

IPCA Laboratories Ltd 26 th August, 2013 BUY

DCB Bank Ltd. 18 th August, 2014 BUY

Gabriel India Ltd. Result Update Presentation Q1 FY17

Madras Cements Ltd 9 th October, 2012 BUY

Granules India Ltd. 21 st July, 2012

Gateway Distriparks Ltd 1 st July, 2011 BUY

Carborundum Universal Ltd 18 th July, 2011 BUY

IPO Report ICICI SECURITIES LTD SUBSCRIBE. Valuation. IPO Details. Research Analyst : Astha Jain

Alembic Pharmaceuticals Ltd 25 th September, 2012

GHCL Ltd. 19 th September, 2016 BUY

SUBSCRIBE. IPO Report HDFC ASSET MANAGEMENT COMPANY LTD. IPO Details. Research Analyst : Astha Jain

Mahindra & Mahindra Ltd.

JK Tyre & Industries Ltd.

Mahindra & Mahindra Ltd.

Market Snap 02 nd June 2018

Mahindra & Mahindra Ltd.

National Institute of Research & Advisory We care for your financial goals

Auto Ancillaries Target Rs th d August Company Background. Jamna Auto. Prominent Market Share 11% 11% 66%

Balaji Amines Ltd 22/11/2017 BUY

Maruti Suzuki India BUY. Performance Update. CMP `9,315 Target Price `10,820. 1QFY2019 Result Update Automobile. Historical share price chart

Meghmani Organics Ltd 24th Aug 2017 BUY

Maruti Suzuki India BUY. Performance Update. CMP `6,705 Target Price `8,552. 2QFY2019 Result Update Automobile. Historical share price chart

LONG TERM SUBSCRIBE. IPO Report HINDUSTAN AERONAUTICS LTD. IPO Details. Research Analyst : Astha Jain

Capacity expansion to drive growth and profitability

SUBSCRIBE. IPO Report BHARAT DYNAMICS LTD. IPO Details. Research Analyst : Astha Jain

Bloomberg Code: ATA IN

Automobiles. Heading Into Strong Earnings Growth Quarter QUARTERLY PREVIEW

SHRIRAM TRANSPORT FINANCE COMPANY LTD

Advisory Desk. TVS Srichakra Ltd. BUY CMP. `355 Target Price `468. Investment rationale. Outlook and valuation. Investment Period 12 Months

Amara Raja Batteries BUY. Performance Highlights. CMP `1,010 Target Price `1,167. 2QFY2017 Result Update Auto Ancillary. 3-year price chart

TVS Motor Company BUY. Performance Highlights. CMP Target Price `39 `45. 2QFY2013 Result Update Automobile. Quarterly highlights (Standalone)

AVOID. IPO Report GARDEN REACH SHIPBUILDERS & ENGINEERS LTD. IPO Details. Research Analyst : Astha Jain

Narnolia Securities Ltd. NAVEEN KUMAR DUBEY 01-Feb-18

Financials/Val. FY15 FY16 FY17 FY18E FY19E. and Suzuki Motor Corporation (13% stake). The company is India s leading 150

Autoline Industries Ltd.

Varroc Engineering Ltd.

JK Paper Ltd 16/02/2018 BUY

Equity Monthly Report

Market Snap 12 th May 2018

Goodyear India BUY. Company Update. CMP Target Price `515 `631. Company Update Tyres. 3-year Daily Price Chart. Key Financials

Cummins India Ltd Bloomberg Code: KKC IN

Bajaj Auto Ltd. CMP: Rs.1426 Recommendation: Buy Target Price: Rs March. 1 P age. 21 st July Key Data Financial Year End

Maruti Suzuki India Ltd. In line with expectations. Realizations drive the performance. Better Product mix aiding realizations growth

Minda Industries Ltd.

Maruti Suzuki (RHS) BUY. Operationally In Line; Reiterate Buy. Automobiles October 31, 2014 RESULT REVIEW. Outlook & Valuation.

Glenmark Pharmaceuticals Ltd 23 rd May, 2012

NRB BEARINGS LTD CMP. 16 July 2018 INR 164. Target Price. Initiating Coverage (BUY) INR 200

Religare Investment Call

Sandhar Technologies Limited

Equity Monthly Report

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,226 Target Price `3,466. 3QFY2017 Result Update Automobile. 3-year price chart

Maruti Suzuki India Ltd.

Maruti Suzuki India Ltd.

SpiceJet ACCUMULATE. Performance Highlights. 4QFY2010 Result Update I Aviation

Bimetal Bearings Limited

Subscribe with Caution to Varroc Engineering Ltd. Strong fundamentals but valuation not supportive

FY17 FY18 FY19E FY20E

NEUTRAL. Automobiles. India

Exide Industries BUY. Auto Components February 03, Volume Recovery & Cost Saving to Cushion Margins RESULT UPDATE

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E

APOLLO TYRES LTD. October 19 th, CMP (Rs.) 194. Key Developments

Bharat Forge Ltd. Rating: BUY. Auto Ancillaries. Bharat Forge STOCK IDEA

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

Equity Monthly Report

Equity Monthly Report

BUY. Strong quarter, bright outlook MAHINDRA CIE AUTOMOTIVE. Target Price: Rs 274. Takeaways from concall. Key drivers (%)

Carborundum Universal Ltd 14/11/2017 BUY

Bulls maintain their grip for the third week in a row

IST Ltd BSE Scrip Code:

Market Snap 14 th July 2018

Market Snap 26 th May 2018

BUY. Suprajit Engineering (SEL) Automobiles

Phillips Carbon Black Ltd

September 21, 2012 Motherson Sumi Systems Limited An emerging global auto-ancillary giant

The Research Report is only for reference purposes for residents in India, but not for the purposes of advising or recommending on any investment.

Equity Monthly Report

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

Endurance Technologies Ltd Auto Ancillary HOLD RETAIL EQUITY RESEARCH. 5 th January 2018 COMPANY UPDATE. CMP Rs. 1,350 TARGET Rs. 1,354 RETURN 0.

ULTRAMARINE & PIGMENTS LTD

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,718 Target Price `4,130. 1QFY2018 Result Update Automobile. 3-year price chart

SUBROS LTD CMP. 28 Dec 2018 INR 266. Initiating Coverage (BUY) Target Price INR 332

Volume No. I Issue No. 22 May 23, 2014 FINANCIAL SUMMARY

Mahindra & Mahindra BUY. CMP Target Price `860 `990. Company Update Automobile

Maruti Suzuki (MSIL IN)

Mahindra & Mahindra. Source: Company Data; PL Research

Bajaj Auto Ltd Scoring on investments

EXIDE INDUSTRIES LTD. 13 April 2018 CMP INR 237. Initiating Coverage (BUY) Target Price INR 294

Muthoot Capital Services Ltd Q2 FY18 Result Analysis

Transcription:

Company Report BROKING DEPOSITORY DISTRIBUTION FINANCIAL ADVISORY Gabriel India Ltd. 4 th November, 2014 BUY CMP(As on 3/11/2014) Rs.83.40 Target Price Rs.115.00 BSE Code 505714 NSE Code GABRIEL Market Cap (Rs Cr.) 1198.21 52 Week High/Low 86.90/19.45 Industry Auto Ancillary Face Value Rs.1.00 Shares O/S 14.37 Cr. EPS(TTM) 3.32 Book Value 20.81 P/E 25.12 P/B 4.00 Shareholding Pattern Gabriel India Limited, the pioneer of Ride Control Products in the country, is the flagship company of Anand and a leading name in the Indian auto component industry. Established in 1961, the company provides the widest range of Ride Control products in India with Shock Absorbers, Struts and Front Forks, catering to Passenger Cars, Utility Vehicles, Commercial Vehicles and Two Wheelers, with over 300 product models on offer. The company has registered sharp results for the quarter ending June 2014. The revenues from operations grew by about 19% to Rs.352.43 crores vs. Rs.295.56 cr. in the year ago quarter while it remained flat on q-o-q. Revenue growth has been mainly driven by vlume increase in two-wheeler and passenger cars segments. Operating profit climbed sharply by ~38% at Rs.27.23 crores as against Rs.19.79 crores in the previous year quarter. The adjusted net profit(before exceptional item) stood at Rs.13.85 crore for the quarter as against Rs.8.68 crore; registering a growth of ~60% and 11% on a sequential basis. On the margins front, operating margin climbed about 102ps at 7.729.37% as against 6.7% while net profit margin expanded 99bps at 3.93% from 2.94% y-o-y. Two/three wheeler has contributed sharp 58% to the total revenues in Q1FY15 as against 53% in Q1FY14. Passenger car has witnessed a fall in contribution to revenues from 33% in Q1FY14 to 31% in Q1FY15; similarly commercial vehicles contributed a mere 11% from 14% y-o-y. Channel mix contribution between original equipment, aftermarket and exports remained same. Valuation Research Analyst: Vineeta Mahnot research@hemonline.com With dominant position in shock absorber market, huge client base, strong brand positioning, increasing geographical presence and deleveraging balance sheet; Gabriel India Ltd. growth prospects and profitability looks promising. We believe the company is trading at an attractive valuation at 18.95x and 13.4x of FY15EPS of Rs.4.4 and FY16EPS of Rs.6.22. We initiate a BUY on the stock with a target price of Rs.115 (appreciation of about 37%) with the medium to long term investment horizon. For Private Circulation Only 1 Hem Research

Business Details Gabriel India Ltd. is a renowned brand synonymous with Shock Absorbers in India having established a significant presence across all automotive customer segments: the Original Equipment Manufacturers (OEM s), Replacement market and Exports. The company provides the widest range of products from front forks and rear shock absorbers for two wheelers, McPherson struts and shock absorbers for passenger cars, Axle, cabin and seat dampers, suspension shock absorber for commercial vehicles and railway shock absorbers. The company has a Technical Collaboration with KYB Corporation, Japan, and KYBSE, Spain. It also has a Technical Collaboration with Yamaha Motor Hydraulic Systems, Japan. Gabriel India that commenced operations in 1961, with a single plant in Mulund, Mumbai today has nine manufacturing facilities spread across the country making Gabriel the leading Automotive OEM supplier for Ride Control products in the country. Manufacturing facilities are:- Nashik- Set up in 1990, this facility manufactures Shock Absorbers and Front Forks for two-wheelers (Scooters & Motor Cycles). The technology is provided by 'Yamaha Motor Hydraulic systems, a 100% subsidiary of Yamaha Motor Company, Japan. This plant caters to Bajaj auto, Yamaha, Honda, Mahindra etc. Hosur- Set up in year 1997 the facility mainly caters to TVSM, Suzuki Motors, Eicher Motors and Yamaha. This plant has made substantial investments to develop innovative products for 2 wheeler market with the backing of Yamaha and KYB of Japan. Parwanoo- Set up in year 2007, this plant has probably the widest range of product families producing Shock absorbers for commercial vehicle and 2 wheelers, Struts for passenger cars and Front forks for motor cycles. The facility mainly caters to TVSM, Tata Motors and Mahindra. Chakan (Pune)- Set up in 1997, this facility delivers suspension products for passenger cars to the widest range of OEMs like Tata Motors, Hyundai, Renault, General Motors, Ford, Toyota Kirloskar & Maruti. This facility is supported by technologies mainly from KYB Corp. that offers suitable products to the foreign auto makers in India. Khandsa (Gurgaon)- This is a facility in a most strategic location of Indian Auto giants at Khandsa, with a comprehensive & Integrated Production System [IPS] for manufacture of gas charged shock absorbers. The plant with technical collaboration with KYB Japan caters to Maruti Suzuki, Honda and Tata. Dewas- Set up in 1992, Dewas plant support requirements of all commercial vehicles like Tata Motors, Ashok Leyland, Eicher, M&M, Force Motors. The facility serves all segments like original equipment, after market and exports. For Private Circulation Only 2 Hem Research

Well diversified business Gabriel India is a brand synonymous with shock absorber with strong market share of 45% with a pan-india network. The company has created it geographical presences across countries like USA, Colombia, Venezuela, Iran, Japan, Africa and Italy. It is planning to expand its network and enter in all six continents. The company plans to focus on exports growth in order to expand its global manufacturing footprint. It also focuses to grow via inorganic growth. The company supplies to most Original Equipment manufacturers (OEM)s in the country; which accounts about 86% of company s total revenues. The company is a dominant player in commercial vehicle (CV) segment with a market share of 80% and derives 10% of its revenues from it. Passenger car segment contributes 30% to the total OEM sales and hold 29% of market share. Two/three wheelers contribute the largest share of 60% to OEM sales and hold 20% of market share. After market in which the company has 51% market share contributes 11% to total sales while remaining 3% is derived from exports. The company has technical tie-ups with few global players like KYB Japan, KYBSE Spain and Yamaha Motor through which it gets access to new techniques, new well-equipped machinery assistance which enhances its product development capabilities. For Private Circulation Only 3 Hem Research

Strong client base The Company has strong base of customers since its inception. The company has been supplying to TVS Motors for both its motor cycles and scooters since many years and in some specific model it is the only source of supply. For Eicher motors strong brand Royal Enfield, Gabriel is a single source supplier. The company has been serving to esteemed clients like TVS Motors, Bajaj Auto, Honda, Yamaha, Suzuki, Mahindra, Piaggio Vehicles etc under two/three wheeler segment. No single original equipment customer counts for more than 20% of sale. Under passenger car segment it has valued customers like Ford, Toyota, Mahindra, Volkswagen, Hyundai, Maruti Suzuki, Honda, Tata Motors, Renault etc. Under commercial vehicles category, Tata Motors, Force motors, Ashok Leyland, Mahindra etc constitute as prestigious customers for Gabriel India. Further, the company also enjoys locational advantage as its manufacturing facilities are located nearby major OEMs which enables it to supply its components easily and with quick time. For Private Circulation Only 4 Hem Research

Standalone Profit & Loss Account Rs. Crore Particulars FY12 FY13 FY14 FY15E FY16E Net sales 1128.23 1205.32 1286.61 1514.34 1814.18 Growth 6.83% 6.74% 17.70% 19.80% Expenditure 1034.16 1122.69 1196.21 1393.19 1654.53 EBITDA 94.07 82.64 90.39 121.15 159.65 Growth -12.15% 9.39% 34.02% 31.78% EBITDA margin 8.34% 6.86% 7.03% 8.00% 8.80% Other income 7.31 4.05 5.63 7.57 9.98 Depreciation & Amortisation 27.64 27.28 27.07 30.87 34.89 EBIT 73.74 59.41 68.95 97.85 134.74 EBIT margin 6.54% 4.93% 5.36% 6.46% 7.43% Interest 17.01 12.29 9.00 7.57 7.15 PBT 56.73 47.12 59.96 90.28 127.59 Tax 9.38 3.05 13.16 27.08 38.28 PAT 47.35 44.07 46.80 63.20 89.31 Adjusted PAT 47.35 44.07 46.80 63.20 89.31 Growth 6.92 6.19 35.04 41.32 Net Profit margins 4.20 3.66 3.64 4.17 4.92 Exceptional item (5.72) 5.94 4.20 0.00 0.00 Reported PAT 53.06 38.14 42.60 63.20 89.31 Equity Capital 7.19 14.37 14.37 14.37 14.37 Res. & Surplus 224.06 242.49 270.81 319.64 391.71 Equity Shares 7.19 14.37 14.37 14.37 14.37 Adjusted EPS 6.59 3.07 3.26 4.40 6.22 Ratios Particulars FY12 FY13 FY14 FY15E FY16E Return on Equity 20.48 17.16 16.41 18.92 21.99 Return on Capital employed 20.81 17.61 19.64 24.95 29.22 Debt/Equity 0.53 0.31 0.23 0.17 0.14 Asset turnover 2.09 2.16 2.19 2.22 2.30 Current Ratio 1.87 1.41 1.36 1.24 1.18 Book value per share 32.18 17.88 19.85 23.25 28.26 Interest coverage 4.34 4.83 7.66 12.93 18.84 For Private Circulation Only 5 Hem Research

Balance Sheet Rs. Crore Particulars FY12 FY13 FY14 FY15E FY16E Share Capital 7.19 14.37 14.37 14.37 14.37 Reserves & Surplus 224.06 242.49 270.81 319.64 391.71 Shareholders funds 231.25 256.86 285.17 334.00 406.07 Borrowings 123.05 80.58 65.97 58.24 54.98 Deferred tax liability 13.34 11.05 9.55 9.55 9.55 Minority Interest 0.00 0.00 0.00 0.00 0.00 Sources of funds 367.64 348.48 360.70 401.80 470.60 Gross block 392.88 459.43 492.12 582.44 697.76 Accumulated Depreciation 179.06 204.00 224.93 255.80 290.69 Net block 213.82 255.43 267.19 326.64 407.07 Capital WIP 3.73 6.39 12.46 8.08 6.05 Investments 0.02 0.02 0.02 0.00 0.00 Deffered tax assets 0.00 0.00 0.00 0.00 0.00 Goodwill on consolidation 0.00 0.00 0.00 0.00 0.00 Inventories 123.07 111.18 116.82 131.69 143.18 Sundry debtors 126.56 121.47 136.08 149.02 162.02 Cash and bank balance 5.59 7.39 4.88 10.40 11.30 Other current assets 0.42 0.52 0.02 0.00 0.00 Loans and advances 66.97 55.22 50.37 55.45 60.29 Total current assets 322.61 295.77 308.16 346.55 376.79 Current liabilities and provisions 172.54 209.13 227.14 279.48 319.31 Net current assets 150.07 86.65 81.02 67.07 57.48 Misc exp 0.00 0.00 0.00 0.00 0.00 Uses of funds 367.64 348.48 360.70 401.80 470.60 For Private Circulation Only 6 Hem Research

Quarterly Financial Highlights Rs. Crore Particulars Q1FY15 Q1FY14 Q4FY14 YoY% QoQ% Revenues 352.43 295.56 335.18 19.24 5.16 Expenditures 325.20 275.77 307.50 17.92 5.76 Operating Profit 27.23 19.79 27.68 37.59 (1.63) Adjusted Net Profit 13.85 8.68 12.53 59.56 10.53 Exceptional item 0.15 ---- 4.2 ---- ---- Reported PAT 13.70 8.68 8.33 57.83 64.47 OPM% 7.72 6.70 8.26 102bps (54bps) NPM % 3.93 2.94 3.74 99bps 19bps Adjusted EPS 0.96 0.60 0.87 60.00 10.34 Past Price movement of the stock GABRIEL (I) (83.4000, 84.1500, 82.0500, 83.4000, +0.5500) 90 90 85 85 80 80 75 70 75 70 65 65 60 60 55 55 50 50 45 45 40 40 35 35 30 30 25 20 25 20 15 15 10 10 5 5 0 0-5 -5 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 For Private Circulation Only 7 Hem Research

www.hemonline.com research@hemonline.com HEM SECURITIES LIMITED MEMBER-BSE,CDSL, SEBI REGISTERED CATEGORY I MERCHANT BANKER MUMBAI OFFICE: 14/15, KHATAU BLDG., IST FLOOR, 40, BANK STREET, FORT, MUMBAI-400001 PHONE- 0091 22 2267 1000 FAX- 0091 22 2262 5991 JAIPUR OFFICE: 203-204, JAIPUR TOWERS, M I ROAD, JAIPUR-302001 PHONE- 0091 141 405 1000 FAX- 0091 141 510 1757 GROUP COMPANIES HEM FINLEASE PRIVATE LIMITED MEMBER-NSE HEM MULTI COMMODITIES PRIVATE LIMITED MEMBER-NCDEX, MCX HEM FINANCIAL SERVICES LIMITED NBFC REGISTERED WITH RBI For Private Circulation Only 8 Hem Research

Disclaimer & Disclosure: This document is prepared for our clients only, on the basis of publicly available information and other sources believed to be reliable. Whilst we are not soliciting any action based on this information, all care has been taken to ensure that the facts are accurate, fair and reasonable. This information is not intended as an offer or solicitation for the purchase or sell of any financial instrument and at any point should not be considered as an investment advise. Reader is requested to rely on his own decision and may take independent professional advise before investing. Hem Securities Limited, Hem Finlease Private Limited, Hem Multi Commodities Pvt. Limited, Directors and any of its employees shall not be responsible for the content. The person accessing this information specifically agrees to exempt Hem Securities Limited, Hem Finlease Private Limited, Hem Multi Commodities Pvt. Limited or any of its affiliates or employees from, any and all responsibility/liability arising from such misuse and further agrees to hold Hem Securities Limited, Hem Finlease Private Limited, Hem Multi Commodities Pvt. Limited or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays. The companies and its affiliates, officers, directors, and employees, including persons involved in the preparation or issuance of this material may from time to time, have long or short positions in, and buy or sell the securities there of, company (ies) mentioned here in and the same have acted upon or used the information prior to, or immediately following the publication. Disclosure of Interest Statement Company Name 1. Analyst Ownership of the Stock No 2. Hem & its Group Company Ownership of the Stock Yes 3. Hem & its Group Companies Director Ownership of the Stock Yes 4. Broking relationship with company covered No Analyst Certification The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. For Private Circulation Only 9 Hem Research